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Foreword
This document is a result of cooperation between the Scientific and
Standardization Committee of the International Society on Thrombosis
and Haemostasis and The Committee/Commission on Quantities and
Units (in Clinical Chemistry) of The International Federation of
Conespondence to:Dr. H. Olesen, Department of Clin. Biochem. KB76 4.2
Rigshospitalet, Tagensvej 20, DK-2200 Denmark
Ciinical Chemistry (IFCC) and The International Union of Pure and
Applied Chemistry (IUPAC). Meetings between the organizations
were held in Amsterdam (NL) 1991-06-29130 and in Munich (D)
t992-01-01t08.
Inlroduclion
Basic research in biology and medicine and innovations in laborato-
ry methodology have greatly increased the range of quantities available
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EXAMPLES
bntry:
I Plasma-
3 Plasminogen activator, tissue type;
4 substance concentration(enz.; procedure)
5 P - Plasminogen activator, tissue type; subst. c.
(enz., IS 861610) = 1 int. unit/l
6 M= 60,000 g/mol
7 Calibrator: WHO 2nd IS 86/670
8 Previous calibrator(s): WHO lst IS 83/517
9 Not recommended t rm(s): Blood plasminogen activator;
t-PA; Tissue plasminogen activator; Vascular plasminogen
actlvator
10 Authority: ISTH/SSC93
Entry:
1 Plasma-
2 or-
3 Macroglobulin:
4 substanceconcentration
5 P - or-Macroglobulin, subst. c. = 3,7 pmol/l
6 M =125,000 glmol
Abbreviolions
Chemical Abstract Service
Enzyme Commission (of the International Union of Bio-
chemistry and Molecular Biology)
International Complement Workshop
International Federation of Clinical Chemistry
International Normalized Ratio
International Reference Preparation
International Standard (by WHO)
International Society of Thrombosis and Haemostasis
Intemational Union of Pure and Applied Chemistry
National Institute for Biological Standards and Control
National Institute of Health (USA)
International System of Units
Scientific and Standardization Committee (of ISTH)
World Health Orsanization
Annex (Recommendotion 1993)
Alphabetic list of Generic Quantities inThrombosis and Haemostasis
Note I
Kind-of-quantity. General nature of a measurable quantity defned
by how measurable quantities of a system and its components are t0 be
related in order to obtain a value of the quantity.
EXAMPLES
length, amount-of-substance, volume fraction.
Note 2
Threshold. Modifier indicating that a kind-of-quantity is defined as
the lowest value of a quantity eliciting a reaction given by the compo-
nent and specified by the procedure.
Note 3
Abbreviations for specificatior?,r. coag.: coagulation; coag diss.:
coagulum dissolution; enz : enzymatic: imm.: immunological; imm.
blott. : immunoblotting.
Note 4
Specifications ecessary or useful for the interpretation ofresults are
stated in the parenthesis following the kind-of-quantity. In the entries
such specifications are indicated in the general sequence: analytical
principle (coag., enz., imm., etc.); procedure (to be substituted bya rec-
ognized procedural name, e. g. the name of a commerciai "kit"); further
optional data, e g. the calibrator used or the scale of possible results.
As apparent from the petit examples the choice of such specifica-
tions is more or less arbitrarv.
Note 5
Abbreviation for activated component: a
EXAMPLES
Coagulation factor V, a; protein C,a inhibition.
Platelets-
Aggregation, ADP-induced;
threshold substance concentration(procedure)
Plts - Aggregation, ADP-induced; threshold subst.c.(procedure;
0 0.5 1 2 5 10 20 pmol/l) = 10 pmol/l
Authority: ISTH/SSCq3
Thrombocytes-
Aggregation, ADP-induced;
threshold substance concentration(procedure)
Trcs - Aggregation, ADP-induced; threshold subst.c.(procedure;
0 0.5 I 2 5 10 20 pmol/l) = 10 pmol/l
Authority: ISTH/SSC93
Platelets-
Aggregation, adrenaline-inducedl
threshold substance concentration(procedure)
Plts - Aggregation, adrenaline-induced; threshold subst.c.(proce-
dure; 0 0.5 I2 5 l0 20 prmol/l) =2 Vmolll
Authority: ISTH/SSC93
Thrombocytes-
Aggregation, adrenaline-induced;
threshold substance concentration(procedure)
CAS
EC
ICW
IFCC
INR
IRP
IS
ISTH
IUPAC
NIBSC
NIH
SI
SSC
wHo
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Trcs-Aggregation, adrenaline-induced; threshold subst.c.(proce-
dure; 0 0.5 1 2 5 10 20 prnol/l) = 2 Umol/l
Authority: ISTH/SSC93
Platelets-
Aggregation, arachidonate-induced;
threshold substance concentration(procedure)
Plts-Aggregation, arachidonate-induced; threshold subst.c.(proce-
dure) = a Pm01/1
Authority: ISTH/SSC93
Thrombocytes-
Aggregation, arachidonate-induced;
threshold substance concentration(procedure)
Trcs-Aggregation, arachidonate-induced; threshold subst.c.(proce-
dure) = a Pmol/l
Authority: ISTH/SSC93
Platelets-
Aggregation, calcium ionophore-induced;
threshold substance concentration(procedure)
Plts-Aggregation, calcium ionophore-induced; threshold
subst.c.(procedure) - a ptmol/l
Authority: ISTH/SSC93
Thrombocytes-
Aggregation, calcium ionophore-induced;
threshold substance concentration(procedure)
Trcs-Aggregation, calcium ionophore-induced; threshold
subst.c.(procedure) = 2 plno171
Authority: ISTH/SSC93
Platelets-
Aggregation, collagen-induced;
threshold mass concentration(procedure)
Plts-Aggregation, collagen-induced; threshold massc. (procedure;
0 0.5 1 2 5 10 20 mg/l) =2mgll
Authority: ISTH/SSC93
Thrombocytes-
Aggregation, collagen-induced;
threshold mass concentration(procedure)
Trcs-Aggregation, collagen-induced; threshold massc. (procedure;
0 0.5 1 2 5 10 20 rng/l) = 2 mgll
Authority: ISTH/SSC93
Platelets-
Aggregation, noradrenaline-induced;
threshold substance concentration(procedure)
Plts-Aggregation, oradrenaline-induced; threshold subst.c. (proce-
dure;0 5 10 20 50 200 pmol/l) = 20 pmol/l
Authority: ISTH/SSC93
Thrombocytes-
Aggregation, noradrenaline-induced;
threshold substance concentration(procedure)
Trcs-Aggregation, noradrenaline-induced; threshold subst.c. (proce-
dure; 0 5 10 20 50 200 prmol/l) = 20 Umol/l
Authority: ISTH/SSC93
Platelets-
Aggregation, ristocetin-inducedl
threshold mass concentration(procedure)
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Plts-Aggregation, ristocetin-induced; threshold massc. (pro-
cedu re ;012g l l )= lg l l
Authority: ISTH/SSC93
Thrombocytes-
Aggregation, ristocetin-induced;
threshold mass concentration(procedure)
Trcs-Aggregation, ristocetin-induced; threshold massc. (pro-
cedu re ;012g l l )=1g11
Authority: ISTH/SSC93
Platelets-
Aggregation, serotonin-induced;
threshold substance concentration(procedure)
Plts-Aggregation, serotonin-induced; threshold subst.c.(pro-
cedure; 0 0.5 1 2 5 10 20 pmol/l) = 5 pmoi/l
Authority: ISTH/SSC93
Thrombocytes-
Aggregation, serotonin-induced;
threshold substance concentration(procedure)
Trcs-Aggregation, serotonin-induced; threshold subst.c.(pro-
cedure; 00.512 5 10 20 ;rmol/l) = 5 pmol/l
Authority: ISTH/SSC93
Platelets-
Aggregation, thrombin-induced;
threshold concentration(procedure)
Plts-Aggregation, thrombin-induced; threshold conc. (procedure;
0 20 50 100 200 500 1000 arb. unit/l) = 200 arb. uniVL
Authority: ISTH/SSC93
Thrombocytes-
Aggregation, thrombin-induced;
threshold concentration(procedure)
Trcs-Aggregation, thrombin-induced; threshold conc. (procedure;
0 20 50 100 200 500 1000 arb. unit/l) = 200 arb. unit/l
Authority: ISTH/SSC93
PIasma-
Antithrombin;
arbitrary substance concentration(enz.; procedure)
P-Antithrombin; arb. subst, c. (enz.; IRP 7211) = I k(int. unit)/l
M = 65,000 g/mol
Calibrator: WHO lst lRP72ll
Not recommended term(s): Antithrombin III; Heparin cofactor I;
Thrombin inhibitor I
Authority: ISTH/SSC93
Plasma-
Antithrombin;
substance concentration(enz.; procedure)
P-Antithrombin; subst. c. (enz.; procedure) = 2.5 pmolfl
M = 65,000 g/mol
Not recommended term(s): Antithrombin III; Heparin cofactor I;
Thrombin inhibitor I
Authority: ISTH/SSC93
Trcs-Aggregation, adrenaline-induced; threshold subst.c.(proce-
dure; 0 0.5 1 2 5 10 20 pmol/l) = 2 Umol/i
Authority: ISTH/SSC93
Platelets-
A ggregation, arachidonate-induced ;
threshold substance concentration(procedure)
Plts-Aggregation, arachidonate-induced; threshold subst.c.(proce-
dure) = a umol/l
Authority: ISTH/SSC93
Thrombocytes-
Aggregation, arachidonate-inducedl
threshold substance concentration(procedure)
Trcs-Aggregation, arachidonate-induced; threshold subst.c.(proce-
dure) = a umoyl
Authority: ISTH/SSC93
Platelets-
Aggregation, calcium ionophore-induced;
threshold substance concentration(procedure)
Plts-Aggregation, caicium ionophore-induced; threshold
subst.c.(procedure) = a ;1t014
Authoriry: ISTH/SSC93
Thrombocytes-
Aggregation, calcium ionophore-inducedl
threshold substance concentration(procedure)
Trcs-Aggregation, calcium ionophore-induced; threshold
subst.c.(procedure) = a pmol/l
Authority: ISTH/SSC93
Platelets-
Aggregation, collagen-inducedl
threshold mass concentration(procedure)
Plts-Aggregation, collagen-induced; threshold massc. (procedure;
0 0.5 1 2 5 10 20 mg/l) =2m9ll
Authonty: ISTH/SSC93
Thrombocytes-
Aggregation, collagen-inducedl
threshold mass concentration(procedure)
Trcs-Aggregation, collagen-induced; threshold massc (procedure;
0 0.5 i 2 5 10 20 mg/l) =2mgll
Authority: ISTH/SSC93
Platelets-
Aggregation, noradrenaline-induced;
threshold substance concentration(procedure)
Plts-Aggregation, oradrenaline-induced; threshold subst.c. (proce-
dure; 0 5 10 20 50 200 prmol/l) = 20 pmol/l
Authority: ISTH/SSC93
Thrombocytes-
Aggregation, noradrenaline-induced ;
threshold substance concentration(procedure)
Trcs-Aggregation, noradrenaline-induced; tireshold subst.c. (proce-
dure; 0 5 10 20 50 200 pmol/l) = 20 Fmol/l
Authority: ISTH/SSC93
Platelets-
Aggregation, ristocetin-induced I
threshold mass concentration(procedure)
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Plts-Aggregation, ristocetin-induced; threshold massc. (pro-
cedu re ;0 l2g l1 )=1911
Authority: ISTH/SSC93
Thrombocytes-
Aggregation, ristocetin-induced;
threshold mass concentration(procedure)
Trcs-Aggregation, ristocetin-induced; threshold massc. (pro-
cedu re ;0 l2gA)= Ig l I
Authority: ISTH/SSC93
Platelets-
Aggregation, serotonin-inducedq
threshold substance concentration(procedure)
Plts-Aggregation, serotonin-induced; threshold subst.c.(pro-
cedure; 00.5 1 2 5 10 20 umol/l) = 5 Umol/l
Authority: ISTH/SSC93
Thrombocytes-
Aggregation, serotonin-induced;
threshold substance concentration(procedure)
Trcs-Aggregation, serotonin-induced; threshold subst.c.(pro-
cedure; 00.5 | 2 5 10 20 pmol/l) = 5 pmol/l
Authority: ISTH/SSC93
Platelets-
Aggregation, thrombin-induced;
threshold concentration(procedure)
Plts-Aggregation, thrombin-induced; threshold conc. (procedure;
0 20 50 100 200 500 1000 arb' unit/l) = 200 arb' unit/l
Authority: ISTH/SSC93
Thrombocytes-
Aggregation, thrombin-induced;
threshold concentration(procedure)
Trcs-Aggregation, thrombin-induced; threshold conc. (procedure;
0 20 50 100 200 500 1000 arb. unit/l) = 200 arb. unit/l
Authonty: ISTH/SSC93
Plasma-
Antithrombin;
arbitrary substance concentration(enz. ; procedure)
P-Antithrombin; arb. subst. c. (enz.; IRP 72l1) = 1 k(int. unit)/l
M = 65,000 g/mol
Calibrator: WHO 1st IRPl2lI
Not recommended term(s): Antithrombin III; Heparin cofactor I;
Thrombin inhibitor I
Authority: ISTH/SSC93
Plasma-
Antithrombin;
substance concentration(enz.; procedure)
P-Antithrombin; subst. c. (enz; procedure) = 2.5 Fmol/l
M = 65,000 g/mol
Not recommended term(s): Antithrombin III; Heparin cofactor I;
Thrombin inhibitor I
Authority: ISTH/SSC93
Plasma-
Antithrombin;
substance concentration(imm.; procedure)
P-Antithrombin; subst.c.(imm. ; procedure) = 2.5 pmoi/l
M = 65,000 g/rnol
Not recommended term(s): Antithrombin III; Heparin cofactor I;
, Thrombin inhibitor I
Authority: ISTH/SSC93
Plasma-
Antithrombin;
arbitrary substance concentration(imm.; procedure)
P-Antithrombin; arb. subst.c.(imm.; IRP 12ll) = | k(int. unit)/l
M = 65,000 g/mol
Calibrator: WHO 1st IRP 7211
Not recommended term(s): Antithrombin III; Heparin cofactor I;
Thrombin inhibitor I
Authority: ISTH/SSC93
Plasma-
Apolipoprotein H;
substance concentration
P-Apolipoprotein H; subst.c.= a mol/l
Not recommended term(s): B-2-glycoprotein I
Authority: IFCC-IUPAC94
Plasma-
Calcium ion(free);
substance concentration
P-Calcium ion(free); subst.c.= 1.22 pnrcll
M = 40.080 g/mol
Not recommended term(s): Coagulation factor IV
Authority: IFCC-IUPAC94
Patient-
Capillary bleeding;
time (procedure)
Pt-Capillary bleeding; time (template) = 300 s
Not recommended term(s): Bleeding time
Authonty: ISTH/SSC93
Plasma-
Cardiolipin antibody;
arbitrary substance concentration(procedure)
P-Cardiolipin antibody; arb. subst.c.(procedure) = a arb. unit/l
Authority : IFCC-IUPAC94
Blood-
Coagulation;
time (procedure)
B-Coagulation; time (procedure) = 4gg t
Not recommended term(s): Coagulation time
Authority: ISTH/SSC93
Plasma-
Coagulation, calcium ion-inducedl
time (procedure)
P-Coagulation, calcium ion-induced; time (procedure) = !Q 5
Not recommended term(s): Recalcification time
Authority: ISTH/SSC93
Plasma-
Coagulation, ecarin-inducedl
time (procedure)
P-Coagulation, ecarin-induced; time (procedure) = a s
Authority: ISTH/SSC93
Note: The name ecarin is derived from EC 3.4.99,21
Echis carinatus prothrombin-activating proteinase
Plasma-
Coagulation, batroxobin-induced ;
time (procedure)
P-Coagulation, batroxobin-induced; time (procedure) = 15 s
Authority: ISTH/SSC93
Note:The name batroxobin sderived from EC 3.4.21.29
Bothrops atrox senne proteinase
Plasma-
Coagulation, russelactivase X-induced;
time (procedure)
P-Coagulation, russelactivase X-induced; time (procedure) = 30 s
Authority: ISTH/SSCg3
Note: The name russelactivase X is derived from Vipera russelli
venom
Plasma-
Coagulation, surface-inducedl
inverse relative time (procedure; norm/actual)
P-Coagulation, surface-induced; inverse rel. time (procedure;
notm/actual) = 0.44
Not recommended term(s): Activated partial thromboplastin time;
aPTT; APTT
Authority: ISTH/SSC93
Plasma-
Coagulation, surface-induced;
relative time (procedure; actual/norm)
P-Coagulation, surface-induced; rel. time (procedure; actual/
norm) = I l
Not recommended term(s): Activated partial thromboplastin time;
aPTT; APTT
Authority: ISTH/SSC93
Plasma-
Coagulation, surface-induced I
time (procedure)
P-Coagulation, surface-induced; time (procedure) = 39 t
Not recommended terrn(s): Activated partial thromboplastin time;
aPTT: APTT
Authority: ISTI{/SSC93
Plasma-
Coagulation, thrombin-induced ;
time (procedure)
P-Coagulation, thrombin-induced; time (procedure) = 15 s
Not recommended term(s): Thrombin time
Authority: ISTH/SSC93
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Calibrator: WHO IS 84/665
Not recommended term(s): Serum
accelerator; Proconverlin; SPCA
Authority: ISTH/SSC93
unitfl
M = 48,000 g/mol
Authority: ISTH/SSC93
Plasma-
Coagulation factor Vll+acarboxy;
relative substance concentration(imm. ; actual/norm)
P-Coagulation factor Vll+acarboxy; rel. subst.c.(imm.; actual/
norm) = f .i
M = 48,000 g/mol
Authonty: ISTH/SSC93
Plasma-
Coagulation factor Vll+acarboxy;
substance concentration(imm.; procedure)
P-Coagulation factor Vll+acarboxy; subst.c.(imm.; procedure) =
10 nmol/l
M = 48,000 g/mol
Authority: ISTH/SSC93
Plasma-
Coagulation factor VII antibody;
arbitrary substance concentration(coag. ; procedure)
P-Coagulation factor VII antibody; arb. subst.c.(coag.; procedure;
0 1 arb. unit) = 0 arb. unit
Not recommended term(s): Coagulation factor VII inhibitor
Authority: ISTH/SSC93
Plasma-
prothrombin conversion CoagulationfactorVlll;
Plasma-
Coagulation factor VII;
relative substance concentration(actual/norm)
P-Coagulation factor VII; rel. subst.c.(actual/norm) = 0.8
M = 48,000 g/mol
Not recommended term(s): Serum prothrombin converslon
accelerator, Proconvertin; SPCA
Authority: ISTH/SSC93
Plasma-
Coagulation factor VII;
substance concentration(imm.; procedure)
P-Coagulation factor VII; subst.c.(imm.; procedure) = 10 nmol/i
M = 48,000 g/mol
Not recommended term(s): Serum prothrombin conversion
accelerator; Proconvertin; SPCA
Authority: ISTH/SSCg3
Plasma-
Coagulation factor VII, activated;
arbitrary substance concentration(coag. ; procedure)
P-coagulation factor vll, a; arb' subst c'(coag ; procedure) = a arb' Coagulation factor VIII;
arbitrary substance concentration(coag. ; procedure)
P-Coagulation factor VIII; arb. subst.c.(coag.; IS 911666)
= 1 k(int. unit)/l
M = 330,000 g/mol
Calibrator: WHO 3rd IS 91/666
Previous calibrator(s): WHO 2nd IS 87/718
Not recommended term(s): VIII:C; Antihemophilic factor; AHF;
Antihemophilic globulin; AHG; Factor VIII clotting activity;
Thrombocyte cofactor A
Authority: ISTH/SSC93
Plasma-
Coagulation factor VIII;
arbitrary substance concentration(enz. ; procedure)
P-Coagulation factor VIII; arb. subst.c.(enz.; Xa activator;
IS 91/666) = 1 k(int. unit)/l
M = 330,000 g/mol
Calibrator: WHO 3rd IS 91/666
Previous calibrator(s): WHO 2nd IS 87/718
Not recommended term(s): VIII:C; Antihemophilic factor; AHF;
Antihemophilic globulin; AHG; Factor VIII clotting activity;
Thrombocyte cofactor A
Authority: ISTH/SSC93
Plasma-
arbitrary substance concentration(imm.; procedure)
P-Coagulation factor VIII; arb. subst.c.(imm.; IS 91/666)
=1k( int .uni t ) / l
M = 330,000 g/mol
Calibrator: WHO 3rd IS 91/666
Previous calibrator(s): WHO 2nd IS 87/718
Not recommended term(s): VIII:C; Antihemophilic factor; AHF;
Antihemophilic globulin; AHG; Factor VIII:Ag; Factor VIII clor
ting activity; Thrombocyte cofactor A
Authority: ISTH/SSC93
PIasma-
Coagulation factor VIII;
substance concentration(imm. ; procedure)
P-Coagulation factor VIII; subst.c.(imm.; procedure) = 0.3 nmol/l
M = 330,000 g/mol
Not recommended term(s): VIII:Ag; Antihemophilic factor; AHF;
Antihemophilic globulin; AHG; Factor VIIIC:Ag; Factor VIII
clotting activity; Thrombocyte cofactor A
Authority: ISTH/SSC93
Plasma-
Coagulation factor VIII, activated;
arbitrary substance concentration(coag. ; procedure)
P-Coagulation factor VIII,a; arb. subst.c.(coag.; pro-
cedure)=aint .uniVl
M = 330,000 g/mol
Authority: ISTH/SSC93
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Plasma-
Coagulation factor VIII antibody;
arbitrary substance concentration(coag. ; procedure)
P-Coagulation factor VIII antibody; arb. subst'c.(coag.; Bethesda;
0 I arb. unit.1 = 0 arb. untt
Not recommended term(s): Circulating aniicoagulant; Coagulation
factor VIII inhibitor
Authority: ISTH/SSC93
Note: Possible procedures: Bethesda; modified Bethesda; Oxford
old; Oxford new, etc.
Plasma-
Coagulation factor VIII antibody;
arbitrary substance concentration(enz. ; procedure)
P-Coagulation factor VIII antibody; arb. subst.c.(enz.; procedure;
0 i arb. unit) = 0 arb. urut
Not recommended term(s): Circulating anticoagulant; Coaguiation
facror VIII inhibitor
Authority: ISTH/SSC93
Plasma-
Coagulation factor VIII antibodY;
arbitrary substance concentration(imm. ; procedure)
P-Coagulation factor VIII antibody; arb. subst.c.(imm.; pro-
cedure;0 1 arb. unit) = 0 arb. unit
Not recommended term(s): Circulating anticoagulant; Coagulation
factor VIII inhibitor
Authority: ISTH/SSC93
Plasma-
Coagulation factor IXl
arbitrary substance concentration(coag. ; procedure)
P-Coagulation factor IX; arb. subst.c.(coag.; IS 84/665) = a int.
unit/l
M = 55,400 g/mol
Calibrator: WHO IS 84/665
Not recommended term(s): Antihemophilic factor B; Christmas
factor; Plasma thromboplastin component; PTC; Thrombocyte c0-
factor II
Authority: ISTH/SSC93
Plasma-
Coagulation factor IX;
arbitrary substance concentration(enz.; procedure)
P-Coagulation factor IX; arb. subst.c.(enz.; IS 84/665) = a int. unit/l
M = 55,400 glmol
Calibrator: WHO IS 84/665
Not recommended term(s): Antihemophilic factor B; Christmas
factor; Plasma thromboplastin component; PTC; Thrombocyte c0-
factor II
Authority: ISTH/SSC93
Plasma-
Coagulation factor IX;
relative substance concentration(imm.; actual/norm)
P-Coagulation factor IX; rel. subst.c.(imm.; actuaVnorm) = I
M = 55,400 g/mol
Not recommended term(s): Antihemophilic factor B; Christmas
factor; Plasma thromboplastin omponent; PTC; Thrombocyte co-
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factor II; Factor IX:Ag
Authority: ISTH/SSC93
Plasma-
Coagulation factor IX;
substance concentration(imm.; procedure)
P-Coagulation factor IX; subst.c.(imm.; procedure) = 80 nmolA
M = 55,400 g/mol
Not recommended term(s): Antihemophilic factor B; Christmas
factor; Plasma thromboplastin component; PTC; Thrombocyte co-
factor II; Factor IX:Ag
Authority: ISTH/SSC93
Plasma-
Coagulation factor IX, activated;
arbitrary substance concentration(coag. ; procedure)
P-Coagulation factor IX,a; arb. subst.c.(coag. ; procedure)
= a arb. unit/l
M = 55,400 g/mol
Authority: LFCC9?
Plasma-
Coagulation factor IX antibody;
arbitrary substance concentration(coag.; procedure)
P-Coagulation factor IX antibody; arb. subst,c.(coag.; Bethesda
modified; 0 1 arb. unit) = 0 arb. untt
Not recommended term(s): Coagulation factor IX inhibitor
Authority: ISTH/SSC93
Plasma-
Coagulation factor X;
arbitrary substance concentration(coag. ; procedure)
P-Coagulation factor X; arb. subst.c.(coag.; IS 84/665) = I k (int.
uni0/l
M = 59,000 g/mol
Calibrator: WHO lst IS 84/665
Not recommended term(s): Autoprothrombin III; Prothrombo-
kinase; Stuart-Prower factor
Authority: ISTH/SSC93
Plasma-
Coagulation factor X;
arbitrary substance concentration(enz.; procedure)
P-Coagulation factor X; arb. subst.c.(enz.; IS 84/665) = 1 k (int.
unit)/l
M = 59,000 g/mol
Calibrator: WHO 1st IS 84/665
Not recommended tenn(s): Autoprothrombin III; Prothrombo-
kinase; Stuart-Prower factor
Authority: ISTFUSSCg3
Plasma-
Coagulation factor X;
relative substance concentration(imm. ; actual/norm)
P-Coagulation factor X; rel. subst.c.(imm.; actual/norm) = 0.8
M = 59,000 g/mol
Not recommended term(s): Autoprothrombin III; Prothrombo-
kinase; Stuart-Prower factor
Authority: ISTH/SSC93
Plasma-
Coagulation factor X;
substance concentration(imm. ; procedure)
P-Coagulation factor X; subst.c.(imm., procedure) =
M = 59,000 g/mol
Not recommended term(s): Autoprothrombin III;
kinase; Stuart-Prower factor
Authority: ISTH/SSC93
Plasma-
160 nmol/l
Prothrombo-
Coagulation factor X, activated;
arbitrary substance concentration(coag. ; procedure)
P-Coagulation factor X,a; arb. subst.c.(coag.; procedure) = a arb.
unit/l
M = 59,000 g/mol
Authority: ISTH/SSC93
Plasma-
Coagulation factor X+acarboxyl
relative substance concentration(imm. ; actual/norm)
P-Coaguiation factor X+acarboxy; rel. subst.c.(imm.; actual/
norm) = |
M = 59,000 glmol
Authority: ISTH/SSC93
Plasma-
Coagulation factor X+acarboxyl
substance concentration(imm.; procedure)
P-Coagulation factor X+acarboxy; subst.c.(imm.; procedure) =
160 nmol/l
M = 59,000 g/mol
Authority: ISTH/SSC93
Plasma-
Coagulation factor X antibody;
arbitrary substance concentration(coag.; procedure)
P-Coagulation factor X antibody; arb. subst.c.(coag.; procedure;
0 1 arb. unit) = 0 arb. unit
Authority: ISTIVSSC93
Plasma-
Coagulation factor XI;
arbitrary substance concentration(coag ; procedure)
P-Coagulation factor XI; arb. subst.c.(coag.; procedure) = a arb.
unit/l
M = 160,000 g/mol
Not recommended term(s): Antihemophilic factor C; Plasma throm-
boplastin antecedent; PTA
Authority: ISTH/SSC93
Plasma-
Coagulation factor XI;
arbitrary substance concentration(enz. ; procedure)
P-Coagulation factor XI; arb. subst.c.(enz.; procedure) = a arb. unit/l
M = 160,000 g/mol
Not recommended term(s): Antihemophilic factor C; Plasma throm-
boplastin antecedent; PTA
Authoritv: ISTH/SSC93
PIasma-
Coagulation factor XI;
relative substance concentration(imm. ; actual/norm)
P-Coagulation factor XI; rel. subst.c.(imm.i actual/norm) = 1
M = 160,000 g/mol
Not recommended term(s): Antihemophilic factor C; Plasma throm-
boplastin antecedent; PTA
Authority: ISTH/SSC93
PIasma-
Coagulation factor XI;
substance concentration(imm. ; procedure)
P-Coagulation factor XI; subst.c.(imm.; procedure) = 30 nmol/l
M = 160,000 g/mol
NoI recommended term(s): Antihemophilic factor C; Plasma throm-
boplastin antecedent; PTA
Authority: ISTH/SSC93
Plasma-
Coagulation factor XI, activated;
arbitrary substance concentration(coag.; procedure)
P-Coagulation factor XI,a; arb. subst.c.(coag.; procedure) = a arb.
unit/l
M = 160,000 g/mol
Authority: ISTH/SSC93
Plasma-
Coagulation factor XI antibody;
arbitrary substance concentration(coag. ; procedure)
P-Coagulation factor XI antibody; arb. subst.c.(coag.; procedure;
0 1 arb. unit) = 0 arb. unit
Not recommended term(s): Coagulation factor XI inhibitor
Authority: ISTH/SSC93
Plasma-
Coagulation factor XII;
arbitrary substance concentration(coag.; procedure)
P-Coagulation factor XII; arb, subst.c.(coag.; procedure) =
1 k (arb. unit)/l
M = 80,000 g/mol
Not recommended term(s): Hageman factor
Authority: ISTH/SSC93
Plasma-
Coagulation factor XII;
arbitrary substance concentration(enz. ; procedure)
P-Coagulation factor XII; arb. subst.c.(enz.; procedure) =
1 k (arb, unit)/l
M = 80,000 g/mol
Not recommended term(s): Hageman factor
Authority: ISTH/SSC93
Plasma-
Coagulation factor XII;
relative substance concentration(imm. ; actual/norm)
P-Coagulation factor XII; rel. subst.c.(imm.; actual/norm) = 0.8
M = 80,000 g/mol
Not recommended term(s): Hageman factor
Authority: ISTH/SSC93
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Plasma-
Coagulation factor XII;
substance concentration(imm. ; procedure)
P-Coagulation factor XII; subst.c.(imm.; procedure) = 370 nmol/l
M = 80,000 g/mol
Not recommended term(s): Hageman factor
Authority: ISTH/SSC93
Plasma-
Coagulation factor XII, activated;
arbitrary substance concentration(coag.; procedure)
P-Coagulation factor XII,a; arb. subst.c.(coag.; procedure) = a arb.
unit/l
M = 80,000 g/mol
Authority: ISTH SSC93
Plasma-
Coagulation factor XII antibody;
arbitrary substance concentration(coag. procedure)
P-Coagulation factor XII antibody; arb. subst.c.(coag.; procedure;
0 1 arb. unit) = 0 arb. unit
Not recommended term(s): Coagulation factor XII inhibitor
Authority: ISTH/SSC93
Plasma-
Coagulation factor XIII;
arbitrary substance concentration(coag. diss. ; procedure)
P-Coagulation factor XIII; arb. subst.c.(coag. diss.; procedure) =
1 arb. unit/l
M = 320,000 g/mol
Not recommended term(s): Fibrin stabilizing factor; Fibrinoligase;
Fibrinase Laki-Lorand factor; Plasma transglutaminase; Plasma
transamidase; Protransglutaminase
Authority: ISTH/SSC93
Plasma-
Coagulation factor XIII;
relative substance concentration(imm. ; actual/norm)
P-Coagulation factor XIII; rel. subst.c.(imm.; actual/norm) = I
M = 320,000 g/mol
Not recommended term(s): Fibrin stabilizing factor; Fibrinoligase;
Fibrinase Laki-Lorand factor; Plasma transglutaminase; Plasma
lransamidase; Protransglutaminase
Authority: ISTH/SSC93
Plasma-
Coagulation factor XIII;
substance concentration(imm. ; procedure)
P-Coagulation factor XIII; subst.c.(imm.; procedure) = 90 nmol/l
M =320,000 glmol
Not recommended term(s): Fibrin stabilizing factor; Fibnnoligase;
Fibrinase Laki-Lorand factor; Plasma transglutaminase; Plasma
transamidase; Protransglutaminase
Authority: ISTH/SSC93
Plasma-
Coagulation factor XIII, activated;
arbitrary substance concentration(procedure)
P-Coagulation factor XIII,a; arb. subst.c.(procedure) = a arb. uniUl
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M =320,000 glmol
Authority: ISTH/SSC93
Plasma-
Coagulation factor XIII antibody;
arbitrary substance concentration(procedure)
P-Coagulation factor XIII antibody; arb. subst.c.(procedure; 0 I arb.
uni t )=garb.uni t
Not recommended term(s): Coagulation factor XIII inhibitor
Authority: ISTH/SSC93
Plasma-
Coagulum lysis;
time (coag. diss,; procedure)
P-Coagulum lysis; time (coag. diss.; procedure) = 6 ks
Not recommended term(s): Euglobulin clot lysis time
Authority: ISTH/SSC93
Blood -
Coagulum retractionl
volume fraction change (procedure)
B-Coagulum retraction; voi.fr. change (procedure) = a
Authority: ISTH/SSC93
Plasma-
Complement Cl esterase inhibitor;
arbitrary subslance concentration(enz. ; procedure)
P-Complement Cl esterase inhibitor; arb. subst.c.(enz.; pro-
cedure)=aarb.unit/ l
M = 105,000 g/mol
Not recommended t rm(s): Cl Inactivator; C1 INA; ClIA; C1 este-
rase inhibitor; Cl INH; Cl inhibitor
Authority:ICW91
Plasma-
Complement C1 esterase inhibitor;
arbitrary substance concentration(imm.; procedure)
P-Complement C1 esterase inhibitor; arb. subst.c.(imm.; procedure)
= a arb. unit/l
M = 105,000 g/mol
Not recommended t rm(s): Cl Inactivator; Cl INA; CIIA; Cl este-
rase inhibitor: Cl INH: C1 inhibitor
Authority:ICW9I
Plasma-
Complement Cl esterase inhibitor;
substance concentration(imm.; procedure)
P-Compiement Cl esterase inhibitor; subst.c.(imm.; procedure) =
2.3 pmolil
M = 105,000 g/mol
Not recommended t rm(s): Cl Inactivator; Cl INA; CIIA; Cl este-
rase inhibitor: Cl INH: C1 inhibitor
Authority:ICW91
Platelets-
Connective tissue-actiyating peptide 3;
arbitrary substance concentration(enz.; procedure)
Plts-Connective tissue-activating peptide 3; arb. subst. c. (enz.;
procedure) = a arb. unit/l
Authority: ISTH/SSC93
Thrombocytes-
Connective tissue-activating peptide 3;
arbitrary substance concentration(enz.; procedure)
Trcs-Connective tissue-activating peptide 3; arb. subst. c. (enz.;
procedure) = arb. unit/l
Authority: ISTH/SSC93
Platelets-
Connective tissue-activating peptide 3;
arbitrary substance concentration(imm.; procedure)
Plts-Connective tissue-activating peptide 3; arb. subst. c. (imm.;
procedure) = arb. unit/i
Authority: ISTH/SSC93
Thrombocytes-
Connective tissue-activating peptide 3;
arbitrary substance concentration(imm. ; procedure)
Trcs-Connective tissue-activating peptide 3; arb. subst. c. (imm.;
procedure) = a arb. unit/l
Authority: ISTH/SSC93
Plasma-
Fibrin+fi brino gen fragments I
arbitrary substance concentration(imm. ; procedure)
P-Fibrin+fibrinogen fragments; arb. subst.c.(imm.; procedure) =
a arb. unit
Not recommended term(s): FDP; Fibrinogen degradation products;
Fibrinogen related antigens; Fibrinogen split products
Authority: ISTH/SSC93
Plasma-
Fibrin. soluble:
arbitrary substance concentration(procedure)
P-Fibrin, soluble; arb. subst.c.(ethanol gelation;0 1 arb. unit) =
0 arb. unit
Authority: ISTH/SSC93
Plasma-
Fibrin. solublel
arbitrary substance concentration(enz. ; procedure)
P-Fibrin, soluble; arb. subst.c.(enz.; procedure) = 0 arb. unitfl
Authonty: ISTH/SSC93
Plasma-
Fibrin D-dimer;
substance concentration(imm. ; procedure)
P-Fibrin D-dimer; subst.c.(imm.;procedure) = 1 nmoll
M = 182,600 g/mol
Authority: ISTH/SSC93
Plasma-
Fibrin fragments;
arbitrary substance concentration(imm. ; procedure)
P-Fibrin fragments; arb. subst.c.(imm. ; procedure)
= a arb. unit/l
Authority: ISTH/SSC93
Plasma-
Fibrinogen;
substance concentration(coag.; procedure)
P-Fibrinogen; subst.c,(coag.; IS 89/644) = 7 pmol/l
M = 340,000 g/moi
Calibrator: WHO IS 89/644
Not recommended term(s): Coagulation factor I
Authority: ISTH/SSC93
Plasma-
Fibrinogen;
substance concentration(imm. ; procedure)
P-Fibrinogen; subst.c.(imm.; procedure) = 7 pmol/l
M = 340,000 g/mol
Not recommended term(s): Coagulation factor I
Authority: ISTH/SSC93
Plasma-
Fibrinogen fragments;
arbitrary substance concentration(procedure)
P-Fibrinogen fragments; arb. subst.c (procedure)
= a arb. unit/l
Authority: ISTH/SSC93
Plasma-
Fibrinopeptide A;
substance concentration(imm.; procedure)
P-Fibrinopeptide A; subst.c.(imm.; procedure) < 2 nmol/l
M = 1,750 glmol
Authority: ISTH/SSC93
Plasma-
Fibrinopeptide B;
substance concentration(imm. ; procedure)
P-Fibrinopeptide B; subst.c.(imm.; procedure) = a nmol/l
M = 1,543 glmol
Authority: ISTH/SSC93
Plasma-
Fibrinopeptide BB(1-14);
substance concentration(imm.; procedure)
P-Fibrinopeptide B9(1-14); subst.c.(imm.; procedure) = 0.5 nmol/l
M = 1,570.8 g/mol
Authority: ISTH/SSC93
Plasma-
Fibrinopeptide BF(|-a2X
substance concentration(imm. ; procedure)
P-Fibrinopeptide BB(1-42); subst.c.(imm.; procedure) =
1.2 nmol/l
M = 4,592.1 glmol
Authority: ISTH/SSC93
Plasma-
Fibrinopeptide BF(15-42);
substance concentration(imm.; procedure)
P-Fibrinopeptide B9(15-42); subst.c.(imm.; procedure) = a nmol./l
M =3,039.9 glmol
Authority: ISTH/SSC93
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PIasma-
Lupus anticoagulantl
arbitrary substance concentration(procedure)
P-Lupus anticoagulant; arb. subst.c.(procedure;0 I arb. unit) =
0 arb, unit
Not recommended term(s): Coagulation i hibiting antibody; Lupus
inhibitor
Authority: ISTH/SSC93
Plasma-
^).-
Macroglobulin substance concentrationl
P-a2-Macroglobulin; subst.c.= 3.7 pmol/l
M =125,000 glmol
Authority: IFCC-IUPAC94
Platelets-
Neutrophilocyte-activating peptide 2;
arbitrary substance concentration(enz. ; procedure)
Plts-Neutrophilocyte-activating peptide 2; arb. subst.c.(enz.; proce-
dure)=sarb.unit/ l
' Authority:ISTH/SSC93
Thrombocytes-
Neutrophilocyte-activating peptide 2;
arbitrary substance concentration(enz. ; procedure)
Trcs-Neutrophilocyte-activating peptide 2; arb. subst.c.(enz.; pro-
cedure)=aarb.unit/ l
Authority: ISTH/SSC93
Platelets-
Neutrophilocyte-activating peptide 2;
arbitrary substance concentration(imm. ; procedure)
Plts-Neufophilocyte-activating peptide 2; arb. subst.c.(imm. ; pro-
cedure)=aarb.unit/ l
Authority: ISTH/SSC93
Thrombocytes-
Neutrophilocyte-activating peptide 2;
arbitrary substance concentration(imm, ; procedure)
Trcs-Neutrophilocyte-activating peptide 2; arb. subst.c.(imm. ; pro-
cedure)=aarb.unit/ l
Authority: ISTH/SSC93
PIasma-
Plasmin inhibitor;
arbitrary substance concentration(enz. ; procedure)
P-Plasmin i hibitor; arb. subst.c.(enz.; procedure) = a arb. unit/l
M = 70,000 g/mol
Not recommended term(s): o2-Antiplasmin s2-AP; Primary fibri-
nolysis inhibitor; Primary plasmin inhibitor
Authority: ISTH/SSC93
Plasma-
Plasmin inhibitor;
arbitrary substance concentration(imm.; procedure)
P-Plasmin inhibitor; arb. subst.c.(imm.; procedure) = a arb. unit/l
M = 70,000 g/mol
Not recommended term(s): o2-Antiplasmin; o2-AP; Primary fibri-
nolysis inhibitor; Primary plasmin inhibitor
Authority: ISTH/SSC93
Plasma-
Plasmin inhibitor;
substance concentration(imm.; procedure)
P-Plasmin i hibitor; subst.c.(imm.; procedure) = 1.0 Umol/l
M = 70,000 g/mol
Not recommended term(s): o2-Antiplasmin; o2-AP; Primary fibri-
nolysis inhibitor; Primary plasmin inhibitor
Authority: ISTH/SSC93
Plasma-
Plasmin-Plasmin hibitor complex;
substance concentration(imm.; procedure)
P-Plasmin-Plasmin inhibitor complex; subst.c.(imm.; procedure) =
1.0 nmol/l
M = 140,000 g/mol
Not recommended term(s): Plasmin-o2-Antiplasmin complex
Authority: ISTH/SSC93
Plasma-
Plasminogen;
arbitrary substance concentration(enz. ; procedure)
P-Plasminogen; arb. subst.c.(enz.; lst BR 781646) = a arb. unit/l
M (Glu-l type) = 92,000 g/mol
Calibrator: 1st Br Ref Prep 78/646 (Glu{ype)
Not recommended term(s): PLG; Plgn; Profibnnolysin
Authority: ISTH/SSC93
Plasma-
Plasminogen;
substance concentration(imm. ; procedure)
P-Plasminogen; subst.c.(imm.; procedure) = 1.3 pmol/l
M (Glu-l type) = 92,000 g/mol
Not recommended t rm(s): PLG; Plgn; Profibrinolysin
Authority: ISTH/SSC93
Plasma-
Plasminogen activator inhibitor 1;
arbitrary substance concentration(enz. ; procedure)
P-Plasminogen activator inhibitor l; arb. subst.c.(enz.; NIBSC
81 l5l2) = 7 arb. unit/l
M = 52,000 glmol
Calibrator: NIBSC 87/5 12 (non-official)
Not recommended term(s): Endothelial cell type PAI; Fast acting
PAI; PAI 1; PA-inhibitor I; Platelet PAI; rPA inhibitor
Authority: ISTH/SSC93
Plasma-
Plasminogen activator inhibitor I ;
arbitrary substance concentration(imm. ; procedure)
P-Plasminogen activator inhibitor 1; arb. subst.c.(imm.; NIBSC
81 l5l2) = 7 arb. unit/l
M = 52,000 g/mol
Calibrator: NIBSC 87/512 (non-official)
Not recommended term(s): Endothelial cell type PAI; Fast acting
PAI; PAI 1; PA-inhibitor I; Platelet PAI; t-PA inhibitor
Authority: ISTH/SSC93
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Plasma-
Plasminogen activator inhibitor 1;
substance concentration(imm.; procedure)
P-Plasminogen activator inhibitor 1; subst.c.(imm.; procedure) =
0.2 nmol/l
M = 52,000 g/mol
Not recommended term(s): Endothelial cell type PAI; Fast acting
PAI; PAI 1;PA-inhibitor I;Platelet PAI; t-PA inhibitor
Authority: ISTH/SSC93
Plasma-
Plasminogen activator inhibitor 1;
substance concentration(enz, ; procedure)
P-Plasminogen activator inhibitor 1; subst.c.(enz.; procedure) = 0.2
nmol/l
M = 52,000 g/mol
Not recommended term(s): Endothelial cell type PAI; Fast acting
PAI; PAI 1; PA-inhibitor I; Platelet PAI; t-PA inhibitor
Authority: ISTH/SSC93
Plasma-
Plasminogen activator inhibitor 2;
arbitrary substance concentration(enz.; procedure)
P-Plasminogen activator inhibitor 2; arb. subst.c.(enz.; procedure) =
a arb. unit/l
M = 60,000 g/mol
Not recommended term(s): PA-inhibitor 2; Placental PAI; PAI 2;
u-PA-inhibitor
Authority: ISTH/SSC93
Plasma-
Plasminogen activator inhibitor 2;
arbiirary substance concentration(imm, ; procedure)
P-Plasminogen activator inhibitor 2; arb, subst.c.(imm ; procedure)
= a arb. unit/l
M = 60,000 g/mol
Not recommended term(s): PA-inhibitor 2;Placental PAI; PAI 2;
u-PA-inhibitor
Authority: ISTH/SSC93
Plasma-
Plasminogen activator inhibitor 2;
substance concentration(imm. ; procedure)
P-Plasminogen activator inhibitor 2; subst.c.(imm.; procedure) =
a mol/l
M = 60,000 g/mol
Not recommended term(s): PA-inhibitor 2; Placental PAI; PAI 2;
u-PA-inhibitor
Authority: ISTH/SSC93
Plasma-
Plasminogen activator, tissue type;
arbitrary substance concentration(enz. ; procedure)
P-Plasminogen activator, tissue type; arb. subst.c.(enz.; IS 86/670)
= 1 int. uniVl
M = 60,000 g/mol
Calibrator: WHO 2nd IS 86i670
Previous calibrator(s): WHO 1st IS 83/517
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Not recommended t rm(s): Blood plasminogen activator; t-PA; Tis-
sue plasminogen activator; Vascular plasminogen activator
Authority: ISTH/SSC93
Plasma-
Plasminogen activator, tissue type;
arbitrary substance concentration(stated time after venistasis;
enz.; procedure)
P-Plasminogen activator, tissue type; arb. subst.c.(10 min after ve-
nistasis: enz,: IS 86/670) = a int. unit/l
M = 60,000 g/mol
Calibrator: WHO 2nd IS 86/670
Previous calibrator(s): WHO lst IS 83/517
Not recommended term(s): Blood plasminogen activator; t-PA;
Tissue plasminogen activator; Vascular plasminogen activat0r
Authority: ISTH/SSC93
Plasma-
Plasminogen activator, tissue type;
substance concentration(enz. : procedure )
P-Plasminogen activator, tissue type; subst.c.(enz.; procedure) =
15 pmol/i
M = 60,000 g/mol
Not recommended t rm(s): Blood plasminogen activator; t-PA;
Tissue plasminogen activator; Vascular plasminogen activator
Authority: ISTH/SSC93
Plasma-
Plasminogen activator, tissue type;
substance concentration(imm. ; procedure)
P-Plasminogen activator, tissue type; subst.c.(imm.; procedure) =
70 pmol,{
M = 60,000 g/mol
Not recommended t rm(s): Blood plasminogen activator; t-PA;
Tissue plasminogen activator; Vascular plasminogen activator
Authority: ISTH/SSC93
Plasma-
Plasminogen activator, tissue type;
substance concentration(stated time after venistasis; enz.; proce-
dure)
P-Plasminogen activator, tissue type; subst.c.(l0 min after veni-
stasis; enz.; procedure) = a pmol/l
M = 60,000 g/mol
NOt recommended term(s): Blood plasminogen activator; t-PA;
Tissue plasminogen activator; Vascular plasminogen activator
Authority: ISTH/SSC93
Plasma-
Plasminogen activator, tissue type;
substance concentration(stated time after venistasis; imm.; proce-
dure)
P-Plasminogen activator, tissue type; subst.c.(l0 min after veni-
stasis; imm.;procedure) = 210 pmol/l
M = 60,000 g/mol
Not recommended term(s): Blood plasminogen activator; t-PA;
Tissue plasminogen activator; Vascular plasminogen activator
Authority: ISTH/SSC93
Plasma-
Plasminogen activator, tissue type-Plasminogen
activator inhibitor 1 complex;
substance concentration(imm. ; procedure)
P-Plasminogen activator, tissue type-Plasminogen activator inhibi-
tor 1 complex; subst.c.(imm.; procedure) = 100 pmol/l
M= 110,000 g/rnol
Not recommended term(s): t-PA-PAI l-complex
Authority: ISTH/SSC93
Plasma-
Plasminogen activator, tissue type'Plasminogen
activator inhibitor 1 complex;
substance concentration
(stated time after venistasis; imm.; procedure)
P-Plasminogen activator, tissue type-Plasminogen activator inhibi-
tor 1 complex; subst.c.(l0 min after venistasis; imm.; procedure) =
250 pmol/l
M= 110,000g/mol
Not recommended term(s): I-PA-PAI 1-complex
Authority: ISTI{/SSC93
PIasma-
Plasminogen activator, urokinase typel
arbitrary substance concentration(procedure)
P-Plasminogen activator, urokinase type; arb. subst.c.(1st IS
81 1594) = a int. unit/l
Calibrator: WHO lst IS 87/594
Previous calibrator(s): WHO IRP 66/46
Not recommended term(s): UK; u-PA; Urokinase
Authority: ISTH/SSC93
Plasma-
Platelet antibody;
arbitrary substance concentration(procedure)
P-Platelet antibody; arb. subst.c.(procedure) = a arb. unit/l
Not recommended term(s): Platelet specific alloantibody; Platelet
autoantibody
Authority: ISTH/SSC93
Plasma-
Platelet factor 4;
arbitrary substance concentration(procedure)
P-Platelet factor 4; arb' subst'c'(IS 83/505) = a int' unit/l
M = 7,800 g/mol
Calibrator: WHO lst IS 83/505
Not recommended term(s): Pl-factor 4; Thrombocyte type heparin
inactivator
Authority: ISTH/SSC93
Plasma-
Platelet factor 4;
substance concentration
P-Platelet factor 4; subst.c.= a mol/l
M =1,800 glmol
Not recommended term(s): Pl-factor 4; Thrombocyte type heparin
inactivator
Authority: ISTH/SSC93
Blood -
Platelets;
number concentration
B-Platelets; num.c. = 250 10e/l
Authority: ISTH/SSC93
Plasma-
Prokallikrein;
arbitrary substance concentration(enz. ; procedure)
P-Prokallikein; arb. subst.c.(enz.; procedure) = a arb. unit/l
M = 86,000 g/mol
Not recommended term(s): Fletcher factor; Prekallikein; Prokini-
nogenase; PK
Authority: ISTH/SSC93
Plasma-
Prokallikrein;
substance concentration
P-Prokallikein; subst.c.= 0.5 pmol/l
M = 86,000 g/mol
Not recommended term(s): Fletcher factor; Prekallikein; Prokini-
nogenase; PK
Authority: ISTH/SSC93
Plasma-
Proplasminogen activator, urokinase typel
substance concentration
P-Proplasminogen activator, urokinase type; subst.c.= 80 pmol/l
M = 54,000 g/mol
Not recommended term(s): UK; u-PA; Urokinase
Authority: ISTH/SSC93
Plasma-
6-keto-
Prostaglandin Flo;
substance concentration
P-6-keto-Prostaglandin F 1 o; subst.c.= a moi/l
M=370.5 glmol
Authority: IFCC-IUPAC94
Plasma-
Protein C;
arbitrary substance concentration(coag.; procedure)
P-Protein C; arb. subst.c.(coag.; IS 861622) = 1 k (int. unit)/l
M = 57,000 g/mol
Calibrator: WHO 1st 15861622
Not recommended term(s): Autoprothrombin II-A
Authority: ISTH/SSC93
Plasma-
Protein C;
arbitrary substance concentration(enz.; procedure)
P-Protein C; arb. subst.c.(enz.;15861622) = 1 k (int. unit)/l
M = 57,000 g/mol
Calibrator: WHO lst IS 86/622
Not recommended term(s): Autoprothrombin II-A
Authority: ISTH/SSC93
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plasma- P-Protein S+acarboxy; subst.c.(imm.; procedure) = 300 nmol/l
Protein C; M = 75,000 g/mol
substance concentration(imm.; procedure) Authority: ISTH/SSC93
P-Protein C; subst.c.(imm.; procedure) = 70 nmol/l
M = 57,000 g/mol Plasma-
Not recommended term(s): Autoprothrombin II-A Protein S+acarboxy (free);
Authonty: ISTH/SSC93 substance concentration(imm.; procedure)
P-Protein S+acarboxy(free); subst.c.(imm.; procedure) =
Plasma- 120 nmol/l
Protein C, activated inhibitor; M = 75,000 g/moi
substance concentration Authority: ISTH/SSC93
P-Protein C,a inhibitor; subst.c.= apmol/l
M = 57,000 g/mol Plasma-
Authority: ISTWSSC93 Prothrombin;
arbitrary substance concentration(coag. ; procedure)
plasma- P-Prothrombin; arb. subst,c.(coag.; procedure) = a arb. unit/l
Protein C+acarboxy; M= 68,700 g/mol
substance concentration(imm.; procedure) Not recommended term(s): Coagulation factor II
P-Protein C+acarboxy; subst.c.(imm.;procedure) = 70 nmol/l Authority: ISTH/SSC93
M = 57,000 g/mol
Authority: ISTH/SSC93 Plasma-
Prothrombin;
plasma- substance concentration(imm.;procedure)
protein S; P-Prothrombin; subst.c.(imm.;procedure) = 1.5pmol/l
arbitrary substance concentration(coag.; procedure) M= 68,700 g/mol
P-Protein S; arb. subst.c.(coag.; procedure) = a arb. unit/l Not recommended term(s): Coagulation factor II
M = 75,000 g/mol Authority: ISTH/SSC 93
Authority: ISTH/SSC93
Plasma-
Plasma- Prothrombin+acarboxYl
Protein s; substance concentration(imm.; procedure)
arbitrary substance concentration(enz.; procedure) P-Prothrombin+acarboxy; subst.c.(imm.; procedure) =
P-Protein S; arb. subst.c.(enz.; procedure) = a arb. unit/l 1.5 pmol/l
M = 75,000 g/mol M = 68,700 g/mol
Authority: ISTH/SSC93 Authority:ISTH/SSCg3
Plasma- Plasma-
Protein S; StrePtokinase antibodY;
substance concentration(imm.; procedure) arbitrary substance concentration(procedure)
P-Protein S; subst.c.(imm.; procedure) = 300 nmol/l P-Streptokinase antibody; arb. subst.c.(coagulurn lysis) = a arb.
M = 75,000 g/mol unit/l
Authority: ISTH/SSC93 Not recommended term(s): Streptokinase inhibitor; Streptokinase
reslstance
Plasma- AuthoritY: ISTH/SSC93
Protein S (free);
substance concentration(coag.; procedure) Plasma-
P-Protein S (free); subst.c.(coag.; procedure) = 120 nmol/l Thrombin-Antithrombin complex;
M = 75,000 g/mol substance concentration
Authority: ISTH/SSC93 P-Thrombin-Antithrombin complex; subst. c = 30 pmol/l
M = 103,000 g/mol
plasma- Not recommended term(s): Thrombin-Thrombin inhibitor I complex
Protein S (free); Authority: ISTH/SSC93
substance concentration(imm. ; procedure)
P-Protein S (free); subst.c.(imm.; procedure) = 120 nmol/l Plasma-
M = 75,000 g/mol Thrombocyte antibody;
Authority: ISTH/SSC93 arbitrary substance concentration(procedure)
P-Thrombocyte antibody; arb. subst.c.(procedure) - a arb. unit/l
plasma- Not recommended term(s): Thrombocyte specific alloantibody;
Protein S+acarboxyl Thrombocyte autoantibody
substance concentration(imm.; procedure) Authority: ISTH/SSC93
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Plasma-
Thrombocyte factor 4;
arbitrary substance concentration(procedure)
P-Thrombocyte factor 4; arb. subst.c.(IS 83/505) = a int. unil4
M = 7,800 g/mol
Calibrator: WHO lst IS 83/505
Not recommended term(s): Pl-factor 4; Thrombocyte type heparin
lnactlvator
Authority: ISTH/SSC93
Plasma-
Thrombocyte factor 4;
substance concentration
P-Thrombocyte factor 4; subst.c.= amol/l
M = 7,800 g/mol
Not recommended term(s): Pl-factor 4; Thrombocyte type heparin
lnactlvat0r
Authority: ISTH/SSC93
Blood *
Thrombocytes;
number concentration
B-Thrombocytes; num.c. = 250 10e/l
Authority: IFCC-IUPAC94
Plasma-
Thromboglobulin;
arbitrary substance concentration(procedure)
P-Thromboglobulin; arb. subst.c.(lS 83/501) = a int. unit/l
M = 8800 g/mol
Calibrator: WHO lst IS 83/501
Authority: ISTH/SSC93
Plasma-
Thromboglobulin;
substance concentration
P-Thromboglobulin; subst.c.= a mol/l
M = 8800 g/mol
Authority: ISTH/SSC93
Plasma-
Thromboxane 82;
substance concentration
P-Thromboxane 82; subst.c.= amol/l
M=310.5 glmol
Authority: ISTH/SSC93
Plasma*
Tissue-factor-pathway coagulation inhibitor;
arbitrary substance concentration(coag.; procedure)
P-Tissue-factor-pathway coagulation inhibitor; arb. subst. c.
(coag.; procedure) = a t6. ,n ,
M = 40,000 g/mol
Not recommended term(s): Extrinsic pathway inhibitor; EPI; Lipo-
protein associated coagulation i hibitor; LACI
Authority: ISTH/SSC93
Plasma-
Tissue-factor-pathway coagulation inhibitor ;
arbitrary substance concentration(enz.; procedure)
P-Tissue-factor-pathway coagulation inhibitor; arb. subst.c.(enz.;
procedure) = a arb. unit/l
M = 40,000 g/mol
Not recommended term(s): Extrinsic pathway inhibitor; EPI; Lipo-
protein associated coagulation i hibitor; LACI
Authority: ISTH/SSC93
Plasma-
Tissue-factor-pathway coagulation inhibitor;
arbitrary substance concentration(imm, ; procedure)
P-Tissue-factor-pathway coagulation inhibitor; arb. subst.c.(imm. ;
procedure) = a arb. unit/l
M = 40,000 g/mol
Not recommended term(s): Extrinsic pathway inhibitor; EPI; Lipo-
protein associated coagulation i hibitor; LACI
Authority: ISTH/SSC93
Plasma-
Tissue-factor-pathway coagulation inhibitor;
relative substance concentration(imm. ; actual/norm)
P-Tissue-factor-pathway coagulation inhibitor; rel. subst.c.(imm.;
actual/norm) = 1.2
M = 40,000 gimol
Not recommended term(s): Extrinsic pathway inhibitor; EP[; Lipo-
protein associated coagulation i hibitor; LACI
Authority: ISTH/SSC93
Plasma-
Tissue-factor-pathway coagulation inhibitor;
substance concentration(imm.; procedure)
P-Tissue-factor-pathway coagulation i hibitor; subst.c.(imm.; pro-
cedure) = 2.5 nmol/l
M = 40,000 g/mol
Not recommended term(s): Extrinsic pathway inhibitor; EPI; Lipo-
protein associated coagulation i hibitor; LACI
Authority: ISTH/SSC93
Plasma-
Tissue thromboplastin factor;
substance concentration(imm.; procedure)
P-Tissue thromboplastin factor; subst.c.(imm.; procedure) -
a mol/l
M = 4'7,000 glmol
Not recommended term(s): Coagulation factor III; TF; Thrombo-
plastin
Authority: ISTH/SSC93
Plasma-
Vitronectin;
substance concentration
P-Vitronectin; subst.c.= 5 pmol/l
M = 75,000 g/mol
Not recommended term(s): Epibolin; S-protein; Serum-spreading
factor
Authority: ISTH/SSC93
Plasma-
Von Willebrand factor;
arbitrary substance concentration(adhesion; procedure)
P-Von Willebrand factor; arb. subst.c.(adhesion; procedure) =
391
a arb. unit/l
Not recommended term(s): Von Willebrand factor activity; risto-
cetin cofactor activity
Authority: ISTI{/SSC93
Note; Component subunits in series of multimers
Plasma-
Von Willebrand factor;
arbitrary substance concentration(imm. ; procedure)
P-Von Willebrand factor; arb. subst.c.(imm.; IS 91/666) = 1 k(int.
unit)/l
Calibrator: WHO 3rd IS 91/666
Previous calibrator(s): WHO 2nd IS 87/718
Not recommended term(s): AHFlike antigen; Factor VIIR:ag;
Factor VIII-related antigen
Authority ISTH/SSC93
No/er Component subunits in series of multimers
Plasma-
Von Willebrand factor;
arbitrary substance concentration(ristocetin cofactor activity;
procedure)
P-Von Willebrand factor; arb. subst.c.(rist. cofact. act.;IS 91/666) =
a int. unit/l
Calibrator: WHO 3rd IS 91/666
Previous calibrator(s): WHO 2nd IS 87/718
Not recommended term(s): Von Willebrand factor activity
Authority: ISTH/SSC93
Plasma-
Von Willebrand factor antibody;
arbitrary substance concentration(ristocetin cofactor activity in-
hibition; procedure)
P-Von Willebrand factor antibody; arb. subst.c.(rist. cofact. act.
inh.; procedure) = a arb. unit/l
Authority: ISTH/SSC93
Plasma-
Von Willebrand factor multimers;
arbitrary substance concentration(imm. blott.; procedure)
P-Von Willebrand factor multimers; arb. subst.c.(imm. blott.; pro-
cedure:0 123 arb. unit) = 2 arb. unit
Authoriry: ISTH/SSC93
Plasma-
Von Willebrand factor multimers(large);
arbitrary substance concentration(imm. blott.; procedure)
P-Von Willebrand factor multimers (large); arb. subst.c.(imm.
blott.; procedure;0123 arb. unit) = 2 arb. unit
authority: ISTH/SSC93
Plasma-
Von Willebrand factor multimers(small);
arbitrary substance concentration(imm. blott. ; procedure)
P-Von Willebrand factor multimers (small); arb. subst.c.(imm.
blott.;procedure;0123 arb. unit) = 2 arb. unit
Authority: ISTH/SSC93
INDEX
ol-cysteine proteinase inhibitor
Kininogen (120,000)
o.,{hiol proteinase inhibitor
Kininogen (120,000)
crr-Antipiasmin
Plasmin inhibitor
crr-AP
Plasmin inhibitor
Activated partial thromboplastin time
Coagulation, surface-induced
AHF
Coagulation factor VIII
AHFJike antigen
Von Willebrand factor
AHG
Coagulation factor VIII
Antihemophilic factor
Coagulation factor VIII
Antihemophilic factor B
Coagulation factor IX
Antihemophilic factor C
Coagulation factor XI
Antihemophilic globulin
Coagulation factor VIII
Antithrombin III
Antithrombin
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aPTT; APTT
Coagulation, surface-induced
Autoprothrombin II-A
Protein C
Autoprothrombin III
Coagulation factor X
Autorosette inhibition factor
Histidine-rich glycoprotein
B-2-glycoprotein I
Apolipoprotein H
Bleeding time
Capillary bleeding
Blood plasminogen activator
Plasminogen activator, tissue type
Cl esterase inhibitor
Complement C1 esterase inhibitor
CI INA
Complement Cl esterase inhibitor
C1 Inactivator
Complement C1 esterase inhibitor
Cl INH
Complement C1 esterase inhibitor
C1 inhibitor
Complement Cl esterase inhibitor
CI/A
Complement C1 esterase inhibitor
Christmas factor Fibrinoligase
Coagulation factor IX Coagulation factor XIII
Circulating anticoagulant Fitzgerald factor
Coagulation factorVlll antibody Kininogen (120,000)
Coagulation factor I Flaujeac factor
Fibrinogen Kininogen (120,000)
Coagulation factor II Fletcher factor
Prothrombin Prokalliketn
Coagulation factor III Hageman factor
Tissue tkomboplastin factor Coagulation factor XII
Coagulation factor IV Heparin cofactor I
Calcium ion(free) Antithrombin
Coagulation factor IX inhibitor HK
Coagulation factor IX antibody Kininogen (120,000)
Coagulation factor V inhibitor HMrK
Coagulation factor V antibody Kininogen (120,000)
Coagulation factor VII inhibitor HMW kininogen
Coagulation factor VII antibody Kininogen (120,000)
Coagulation factor VIII inhibitor HRG
Coagulation factor VIII antibody Histidine-rich glycoprotein
Coagulation factor XI inhibitor HRGP
Coagulation factor XI antibody Histidine-rich glycoprotein
Coagulation factor XII inhibitor LACI
Coagulation factor XII antibody Tissue-factor-pathway coagulation i hibitor
Coagulation factor XIII inhibitor Lipoprotein-associated coagulation i hibitor
Coagulation factor XIII antibody Tissue-factor-pathway coagulation i hibitor
Coagulation i hibiting antibody LK
Lupus anticoagulant Kininogen (68,000)
Coagulation time Lupus inhibitor
Coagulation Lupus anticoagulant
Dermatan sulphate cofactor P & P
Heparin cofactor II Coagulation, tissue factor-induced
Endothelial cell type PAI PA-inhibitor 2
Plasminogen activator inhibitor I Plasminogen activator inhibitor 2
EPI PA-inhibitor I
Tissue-factor-pathway coagulation i hibitor Plasminogen activator inhibitor 1
Epibolin PAI 1
Vitronectin Plasminogen activator inhibitor 1
Euglobulin clot lysis time PAI 2
Coagulum lysis Plasminogen activator inhibitor 2
Extrinsic pathway inhibitor PK
Tissue-factor-pathway coagulation i hibitor Prokallikrein
Factor IX:Ag Pl-factor 4
Coagulation factor IX Platelet factor 4 and Thrombocyte factor 4
Factor VIII clotting activity Placental PAdll
Coagulation factor VIII Plasminogen activator inhibitor 2
Factor Vlll-related antigen Plasma thromboplastin antecedent
Von Willebrand factor Coagulation factor XI
Factor VIIIC:Ag Plasma thromboplastin component
Coagulation factor VIII Coagulation factor IX
Factor VIIIR:Ag Plasma transamidase
Von Willebrand factor Coagulation factor XIII
Fast acting PAI Plasma transglutaminase
Plasminogen activator inhibitor 1 Coagulation factor XIII
FDP Plasmin-cr2-Antiplasmin complex
Fibrin + fibrinogen fragments Plasmin-plasmin inhibitor complex
Fibrin stabilizing factor Platelet autoantibody
Coagulation factor XIII Platelet antibody
Fibrinase Laki-Lorand factor Platelet PAI
Coagulation factor XIII Plasminogen activator inhibitor 1
Fibrinogen degradation products Platelet specific alloantibody
Fibrin + fibrinogen fragments Platelet antibody
Fibrinogen related antigens PLG
Fibrin + fibrinogen fragments Plasminogen
Fibrinogen split products Plgn
Fibrin + fibrinogen fragments Plasminogen
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PP{ime
Coagulation, tissue factor-induced
Prekallikrein
Prokallikein
Primary fibrinolysis inhibitor
Plasmin inhibitor
Primary plasmin inhibitor
Plasmin inhibitor
Proaccelerin
Coagulation factor V
Proaccelerin accelerator globuLn
Coagulation factor V
Proconvertin
Coagulation factor VII
Profibrinolysin
Plasminogen
Prokininogenase
Prokallikein
Prothrombin complex
Coagulation, tissue factor-induced
Prothrombin time
Coagulation, tissue factor-induced
Prothrombin time ratio
Coagulation, tissue factor-induced
Prothrombin (factors II + VII + X)
Coagulation, tissue factor-induced
Prothrombin + proconvertin
CoagUlation, tissue factor-induced
Prothrombokinase
Coagulation factor X
Protransglutaminase
Coagulation factor XIII
PTA
Coagulation factor XI
PTC
Coagulation factor IX
Recalcification time
Coagulation, calcium ion-induced
Ristocetin cofactor activity
Von Willebrand factor
S-protein
Vitronectin
Serum protlrombin conversion accelerator
Coagulation factor VII
Serum-spreading factor
Vitronectin
SPCA
Coagulation factor VII
Streptokinase inhibitor
Sfreptokinase antibody
S treptokinase r sistance
Streptokinase antibody
Stuarl-Prower factor
Coagulation factor X
t-PA
Plasminogen activator, tissue type
t-PA inhibitor
Plasminogen activator inhibitor 1
I-PA-PAI l-complex
Plasminogen activator, tissue type-Piasminogen activator inhib.
TF
Tissue thromboplastin factor
The labile factor
Coagulation factor V
Thrombin inhibitor I
Antithrombin
Thrombin inhibitor II
Heparin cofactor II
Thrombin time
Coagulation, thrombin-induced
Thrombin-Thrombin inhibitor I complex
Thrombin-Antithrombin complex
Thrombocyte autoantibody
Thrombocyte antibody
Thrombocyte cofactor II
Coagulation factor IX
Thrombocyte specifi c alloantibody
Thrombocyte antibody
Thrombocyte fype heparin inactivator
Platelet factor 4 and Thrombocyte factor 4
Thromboplastin
Tissue thromboplastin factor
Thrbmboplastin time
Coagulation, tissue factor-induced
Tissue plasminogen activator
Plasminogen activatbr, tissue type
u-PA
Plasminogen activator, urokinase type and
Proplasminogen activator, urokinase type
u-PA-inhibitor
Plasminogen activator inhibitor 2
UK
Plasminogen activator, urokinase type and
Proplasminogen activator, urokinase type
Urokiflase
Plasminogen activator, urokinase type and
Proplasminogen activator, urokinase type
Vascular plasminogen activator
Plasminogen activator, tissue type
VIII:Ag
Coagulation factor VIII
VIII:C
Coagulation factor VIII
Von Willebrand factor activity
Von Willebrand factor
Williams factor
Kininogen (120.000)
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